MedTrace Logo

Evaluation of Three Daily Disposable Contact Lenses

NCT02568254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2017-07-17

Study results available
· View outcomes & findings →

Summary

This is a single-site, 8-visit, double-masked, cross-over study involving three marketed products as study lenses. Participants will be randomly assigned each lens type, which will be worn for approximately two weeks (12 +/- 2 days) each. Participants will undergo a minimum washout period of 3 days before entering the study and undergo a minimum 7 day washout period between dispensing each lens type.

Conditions

  • Visual Acuity

Interventions

DEVICE

Lens 1 (etafilcon A)

Each lens type will be worn for approximately 2 weeks (12 +/- 2 days).

DEVICE

Lens 2 (nelfilcon A)

Each lens type will be worn for approximately 2 weeks (12 +/- 2 days).

DEVICE

Lens 3 (nesofilcon A)

Each lens type will be worn for approximately 2 weeks (12 +/- 2 days).

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-03
Primary Completion
2016-01-18
Completion
2016-01-18
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02568254 on ClinicalTrials.gov